We studied steps that make up the initial and steady-state phases of nitric
oxide (NO) synthesis to understand how activity of bovine endothelial NO s
ynthase (eNOS) is regulated. Stopped-flow analysis of NADPH-dependent flavi
n reduction showed the rate increased from 0.13 to 86 s(-1) upon calmodulin
binding, but this supported slow heme reduction in the presence of either
Arg or N-omega-hydroxy-L-arginine (0.005 and 0.014 s(-1), respectively, at
10 degrees C). O-2 binding to ferrous eNOS generated a transient ferrous di
oxy species (Soret peak at 427 nm) whose formation and decay kinetics indic
ate it can participate in NO synthesis. The kinetics of heme-NO complex for
mation were characterized under anaerobic conditions and during the initial
phase of NO synthesis. During catalysis heme-NO complex formation required
buildup of relatively high solution NO concentrations (>50 nM), which were
easily achieved with N-omega-hydroxy-L-arginine but not with Arg as substr
ate. Heme-NO complex formation caused eNOS NADPH oxidation and citrulline s
ynthesis to decrease 3-fold and the apparent K-m for O-2 to increase 6-fold
. Our main conclusions are: 1) The slow steady-state rate of NO synthesis b
y eNOS is primarily because of slow electron transfer from its reductase do
main to the heme, rather than heme-NO complex formation or other aspects of
catalysis. 2) eNOS forms relatively little heme-NO complex during NO synth
esis from Arg, implying NO feedback inhibition has a minimal role. These pr
operties distinguish eNOS from the other NOS isoforms and provide a foundat
ion to better understand its role in physiology and pathology.